Current situation of endotoxin retentive filter

Blood Purification

Volumn 27, Issue SUPPL. 1, 2009, Pages 28-35

  Tsuchida, Kenji ^a   Nakamura, Masayuki ^a   Yoshikawa, Kazuhiro ^a   Minakuchi, Jun ^a   Takesawa, Shingo ^b  

^a Kawashima Hospital   (Japan)

^b KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Central dialysis fluid delivery system; Endotoxin retentive filter; Logarithm reduction value; Ultrapure dialysis fluid

Indexed keywords

DIALYSIS FLUID; ENDOTOXIN;

BACTERIAL COUNT; CENTRAL DIALYSIS FLUID DELIVERY SYSTEM; CONFERENCE PAPER; DIALYSIS EQUIPMENT AND SUPPLIES; DIALYSIS MEMBRANE; ENDOTOXIN RETENTIVE FILTER; JAPAN; MEMBRANE FILTER; PRIORITY JOURNAL; PROVOCATION TEST; RENAL REPLACEMENT THERAPY; REVERSE OSMOSIS; SAFETY; TREATMENT OUTCOME; ULTRAFILTRATION;

BACTERIA; ENDOTOXINS; HUMANS; JAPAN; MEMBRANES, ARTIFICIAL; QUALITY CONTROL; RENAL DIALYSIS;

EID: 68149125339     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000213495     Document Type: Conference Paper

References (13)

1. Committee of Renal Data Registry: Overview of Regular Dialysis Treatment in Japan, 31 December 2007. Tokyo, Japanese Society for Dialysis Therapy, 2007.
2. Tsuchida K, Takemoto Y, Yamagami S, Edney H, Niwa M, Tsuchiya M, Kishimoto T, Shaldon S: Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods. Nephron 1997; 75:438- 443.
3. Tsuchida K, Nakatani T, Sugimura K, Yshimura R, Matsuyama M, Takemoto Y: Biological reactions resulting from endotoxin adsorbed on dialysis membrane: an in vitro study. Ar tif Organs 2004; 28: 231-234 .
4. Baz M, Durand C, Ragon A, Jaber K, Andrieu D, Merzouk T, Purgus R, Olmer M, Reynier JP, Berland Y: Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Ar tif Organs 1991; 1 4 : 681- 685.
5. Go I, Takemoto Y, Tsuchida K, Sugimura K, Nakatani T: The effect of ultrapure dialysate on improving renal anemia. Osaka City Med J 2007; 53:17-23.
6. Lederer SR, Schiffl H: Ultrapure dialysis fluid lowers the cardiovascular morbidity in patients on maintenance hemodialysis by reducing continuous microinflammation. Nephron 2002; 91: 452-455.
7. Rudnick JR, Arduino MJ, Bland LA, Cusick L, McAllister SK, Aguero SM, Jarvis WR: An outbreak of pyrogenic reactions in chronic hemod ia lysis patients associated w it h hemodialyzer reuse. Artif Organs 1995; 19:289- 294.
8. Ward RA: Dialysis water as a determinant of the adequacy of dialysis. Semin Nephrol 2005; 25:102-111.
9. Schiffl H, Lang SM, Stratakis D, Fischer R: Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 2001; 16: 1863- 1869.
10. Schiffl H, Lang SM, Fischer R: Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant 2002; 17 : 1814 - 1818.
11. EBPG Expert Group on Renal Transplantation: European best practice guidelines for renal transplantation. Section I V: Dialysis fluid purity. Nephrol Dial Transplant 2002; 17:S 45-S62.
12. Kawanishi H, Akiba T, Masakane I, Tomo T, Mineshima M, Kawasaki T, Hirakata H, Akizawa T: The standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy (JSDT) 2008. Ther Apher Dial 20 09;13:161-166.
13. Canaud B: Microbiological purity of dialy-sate: rationale and technical aspects. Blood Purif 2000; 18:200-213.